Cells and biomaterials in cartilage tissue engineering.

Cartilage injuries are challenging to heal due to limited intrinsic repair mechanisms. Osteoarthritis prevalence is rising with an aging global population. Current treatments fail to fully restore tissue function. Early cell-based therapies emerged in the 1990s with limited success. Research shifted toward 3D scaffolds to better mimic native cartilage. Scaffolds aim to provide structural support and biochemical cues. This gap motivated exploration of new cell sources and materials. No prior work had resolved long-term integration and functionality.

This review evaluates cell sources and scaffold materials for cartilage tissue engineering. It aims to synthesize current knowledge on cell types and biomaterials. The goal is to identify promising strategies for clinical translation. The study addresses the need for durable and functional cartilage repair. It focuses on comparing cell-based approaches and scaffold designs. No prior work had systematically reviewed these combinations. The study seeks to inform future scaffold development efforts. It highlights challenges in achieving mechanical and biological integration.

The review approach involved analyzing peer-reviewed literature on cell-based cartilage therapies. Key findings were synthesized from studies published between 1990 and the present. The authors evaluated cell sources such as chondrocytes and stem cells. Scaffold materials were categorized by composition and structural properties. Comparative analysis focused on mechanical and biological performance. No specific experimental data was collected for this review. The synthesis emphasized evidence-based trends and limitations. The authors highlighted areas requiring further investigation.

Chondrocytes remain a primary cell source for engineered cartilage. Stem cells offer potential for differentiation and proliferation. Scaffold materials include natural and synthetic polymers. Natural scaffolds like collagen and hyaluronic acid are biocompatible. Synthetic scaffolds such as poly(lactic-co-glycolic acid) provide tunable properties. 3D printing techniques enable precise scaffold architecture. Mechanical strength and degradation rates vary by material. The review suggests that hybrid scaffolds may offer optimal performance.

The authors propose that cell-scaffold combinations improve cartilage regeneration outcomes. Synthesis of findings suggests that scaffold design influences cell behavior. No single cell source or material has emerged as universally superior. The review highlights the need for standardized evaluation criteria. Authors suggest that stem cell use may expand therapeutic options. Scaffold biocompatibility and mechanical properties remain critical factors. The study emphasizes the importance of mimicking native cartilage structure. Authors conclude that further research is needed to optimize clinical translation.